top of page
Rechercher

Journal Club: Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade S

  • Cell: olume 181, ISSUE 4, P905-913.e7, May 14
  • 22 juin 2020
  • 1 min de lecture

Highlights

  • Soluble human ACE2 can inhibit SARS-CoV-2 infections

  • SARS-CoV-2 can directly infect human blood vessel and kidney organoids

  • Human organoids as model systems to study SARS-CoV-2 infections/COVID-19

 
 
 
bottom of page